Dell Works with Paladin to Double Down on Pro Bono Efforts
Mymee, Inc. Expands Executive Leadership Team to Support Commercial Growth
Startup is using robots for rebar assembly
Paladin Reflects on their Path to Success
Accelerate NY Seed fund invested $100,000 in cancer drug developer TargaGenix Inc. The company is commercializing a novel chemotherapy agent developed at Stony Brook University.
Click Here to to Read More